Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Telemedicine for Retinal Disease During the COVID-19 Pandemic: Survey of the Patient Perspective.
Journal: Ophthalmology and therapy
Published: June 26, 2022
A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration.
Journal: American journal of ophthalmology
Published: September 29, 2021
Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: July 24, 2020
Showing 1-3 of 3
Last Updated: 09/26/2026